AbbVie to Showcase Migraine Portfolio and Pipeline During the 16th European Headache Federation Congress |
| December 06, 2022 | December 2022 Bond Updates |
|
-- Fifteen abstracts underscore AbbVie's commitment to people living with migraine -- AbbVie to present late-breaking data from the Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) study on neck pain with headache in people with and without migraine -- Results from the... |
| View more at: https://www.prnewswire.com:443/news-releases/abbvie-to-showcase-migraine-portfolio-and-pipeline-during-the-16th-european-headache-federation-congress-301695212.html |
| Related News |
|